Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards

The NHLBI Phase IIB Bridge Award (RFA-HL-26-014) and the NHLBI Phase IIB Small Market Award (RFA-HL-26-015) Programs can provide up to $3.5 Million over three (3) years to continue the commercialization of novel products in the NHLBI mission space, specifically towards the completion of milestones necessary to achieve regulatory approval. This work must represent an extension of work completed under an SBIR/STTR Phase II award. This funding opportunity also encourages business relationships between small businesses and third-party investors or strategic partners. The evidence of secured third-party investment will be strongly considered in the review of the applications and in making funding decisions. Please review the notices of funding opportunities (NOFOs) for more information.

NIH support is particularly important for innovative products that have small markets. The National Center for Advancing Translational Sciences (NCATS) will consider co-funding awards in the small market program (RFA-HL-26-015) that address rare diseases and pediatric populations, particularly platforms that address multiple rare diseases. Applicants who believe their technologies are relevant to the small market opportunity are encouraged to read this opportunity for specific definitions and areas of interest. 

Applications to both programs will be accepted starting on January 25, 2025, with an application deadline of February 25, 2025. An informational Webinar will be held on January 23, 2025, at 2:00 p.m. ET.